GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Price-to-Funds-From-Operations

ANRO (Alto Neuroscience) Price-to-Funds-From-Operations : (As of Apr. 10, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Alto Neuroscience Business Description

Traded in Other Exchanges
N/A
Address
369 South San Antonio Road, Los Altos, CA, USA, 94022
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.